Importantly, we found that ME2 was correlated with the GBM MES phenotype and promoted PMT and reprograming of the lipogenesis pathway via AMPK–SREBP-1–ACSS2 in glioma cells. The gene discussed is ME2; the disease is central nervous system cancer.